Paytm sells PayPay stake to SoftBank for $279.2 million

Date:

Share post:


Paytm has agreed to sell its stake in Japanese payments firm PayPay to SoftBank for $279.2 million, as the Indian firm sheds non-core assets following a bruising regulatory clampdown earlier this year.

The sale of Paytm’s stake in PayPay, which it received through acquisition rights six years ago, follows months of restructuring at the Indian firm that saw the company sell its entertainment ticketing unit to Zomato for $246 million in August.

PayPay, controlled by SoftBank and Yahoo Japan parent Z Holdings, is a leading payments app in Japan.

The stake sale will boost Paytm’s cash reserves to $1.46 billion as it attempts to recover market share in India’s fiercely competitive payments market. The company’s banking affiliate was severely restricted by regulators in January, leading to an exodus of customers to rival services.

Shares in Paytm have nearly tripled since June after India’s payments regulator allowed it to resume adding customers to its flagship UPI service. The company reported its first quarterly profit in September, though this was largely due to proceeds from asset sales rather than operational improvements.

“We are grateful to Masayoshi-san and the PayPay team for giving us the opportunity to together create a mobile payment revolution in Japan,” Paytm said in a statement. “We remain fully committed and will continue to support PayPay’s product and technology innovations in future. We are working on introducing new AI-powered features to accelerate PayPay’s vision in Japan.”

Saturday’s deal marks the end of Paytm’s relationship with SoftBank, which divested its remaining shares in June after being an early backer through its Vision Fund.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Profitable Klarna files for a potentially blockbuster IPO

Swedish fintech Klarna took the next step in its highly anticipated U.S. IPO on Friday when it...

Google is replacing Google Assistant with Gemini

Google will replace Google Assistant on Android phones with Gemini later this year, the company announced on...

Testing the Uber-Waymo robotaxi, Rivian goes hands-free, and Travis Kalanick has AV FOMO 

Welcome back to TechCrunch Mobility — your central hub for news and insights on the future of...

Tern AI’s low-cost GPS alternative actually works

We’ve all experienced that moment of frustration when the GPS glitches and you miss an exit on...

China is reportedly keeping DeepSeek under close watch

China appears to think homegrown AI startup DeepSeek could become a notable tech success story for the...

iPhone and Android users will soon be able to send encrypted RCS messages to each other

Text messages sent between iPhones and Android devices will soon benefit from end-to-end encryption (E2EE), after the...

Developer of Lockbit ransomware gets extradited to the United States

Rostislav Panev, a 51-year-old dual Russian-Israeli national, who is accused of being a key developer for the...

US lawmakers urge UK spy court to hold Apple ‘backdoor’ secret hearing in public

A group of bipartisan U.S. lawmakers are urging the head of the U.K.’s surveillance court to hold...